NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
- Update frequency
- every 3 days
- Episodes
- 369
- Years Active
- 2008 - 2025
From Diagnosis to Treatment: Challenges in Glioblastoma Care
Glioblastomas are fast, aggressive, and resistant to many standard therapies. Dr. Lauren Schaff, a neuro-oncologist at Memorial Sloan Kettering Cancer Center, expla…
Climate Change in the Clinic: Examining Neurological Impacts
The impacts of climate change present a growing threat to brain health. Rising heat, air pollution, and oxidative stress appear to worsen conditions like strok…
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
The FDA approval of vorasidenib marks a new era for mutant isocitrate dehydrogenase (mIDH) gliomas. Approved in 2024 for grade 2 tumors after surgery, it doubled pr…
mIDH Gliomas Explained: Characteristics and Management Strategies
Defined by the production of 2-hydroxyglutarate, mutant isocitrate dehydrogenase (mIDH) gliomas are diffuse, slow-growing tumors. Managing these tumors requires per…
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
The FDA approval of vorasidenib marks a new era for mutant isocitrate dehydrogenase (mIDH) gliomas. Approved in 2024 for grade 2 tumors after surgery, it doubled pr…
Climate Change in the Clinic: Examining Neurological Impacts
The impacts of climate change present a growing threat to brain health. Rising heat, air pollution, and oxidative stress appear to worsen conditions like strok…
From Diagnosis to Treatment: Challenges in Glioblastoma Care
Glioblastomas are fast, aggressive, and resistant to many standard therapies. Dr. Lauren Schaff, a neuro-oncologist at Memorial Sloan Kettering Cancer Center, expla…
mIDH Gliomas Explained: Characteristics and Management Strategies
Defined by the production of 2-hydroxyglutarate, mutant isocitrate dehydrogenase (mIDH) gliomas are diffuse, slow-growing tumors. Managing these tumors requires per…
Optimizing TK2d Care Through a Multidisciplinary Approach
Guest: Kaitlin Batley, MD
Guest: Esra Caylan, MD
Thymidine kinase 2 deficiency (TK2d) presents with a variability of symptoms, including res…
Optimizing TK2d Care Through a Multidisciplinary Approach
Guest: Kaitlin Batley, MD
Guest: Esra Caylan, MD
Thymidine kinase 2 deficiency (TK2d) presents with a variability of symptoms, including res…
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Guest: B. Joy Snider, MD, PhD
Guest: Charles P. Vega, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managemen…
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managem…
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managem…
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managem…
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), …
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the management of Alzheimer's disease (AD), r…
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
Guest: Jerome A. Barakos, MD
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Amyloid-related imaging abnormalities (ARIA) represent a critical challen…
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Guest: B. Joy Snider, MD, PhD
Guest: Jerome A. Barakos, MD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managem…
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (ARIA) represent a critical challe…
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Guest: Charles P. Vega, MD
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (ARIA) represent a critical challenge in the managemen…